ADiTx Therapeutics Inc ADTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/14/21 EDT
2.94quote price arrow up+0.04 (+1.38%)
Volume
333,599
52 week range
1.62 - 9.58

...

Loading . . .
  • Open2.94
  • Day High3.09
  • Day Low2.92
  • Prev Close2.94
  • 52 Week High9.58
  • 52 Week High Date08/06/20
  • 52 Week Low1.62
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap42.78M
  • Shares Out14.55M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change41.35

KEY STATS

  • Open2.94
  • Day High3.09
  • Day Low2.92
  • Prev Close2.94
  • 52 Week High9.58
  • 52 Week High Date08/06/20
  • 52 Week Low1.62
  • 52 Week Low Date09/24/20
  • Market Cap42.78M
  • Shares Out14.55M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change41.35

RATIOS/PROFITABILITY

  • EPS (TTM)-1.34
  • P/E (TTM)-2.19
  • Fwd P/E (NTM)6.26
  • EBITDA (MRQ)-13.798M
  • ROE (MRQ)-365.54%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)28.05%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ADiTx Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Aditx Therapeutics, Inc. is a pre-clinical stage, life sciences company. The Company is focused on developing technologies on improving the health of the immune system through immune reprogramming and monitoring. The Company’s immune reprogramming technology is at the pre-clinical stage and is designed to retrain the immune system to induce tolerance. The Company’s immune monitoring technology is designed to provide a personalized profile of the immune system. The Company is...
Amro Albanna
Chairman
Rowena Albanna
Chief Operating Officer
Corinne Pankovcin
Chief Financial Officer
Address
2569 Wyandotte, St., Suite 101
Mountain View, CA
94043
United States